Nerve Agent Antidote Autoinjectors and Trainers
Awarded Limited / Sole Source Justification Posted
- Solicitation number
- 19AQMM23D0093
- Agency
- Office of Acquisition Management Department of State
- Set-aside
- No set-aside
Opportunity facts
- Contract number
- 19AQMM23D0093-19AQMM23F3176 Federal contract award
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
Notice details come from SAM.gov. Updated .
About this opportunity
The Department of State Office of Acquisition Management published a Limited/Sole Source Justification Notice for up to 314,660 units of Meridian Medical Technologies' FDA-approved nerve agent antidote autoinjectors called DuoDote, as well as 2,500 training devices, with an indefinite delivery, indefinite quantity contract valued at an unknown amount awarded to Meridian Medical Technologies on a sole source basis. The justification cites FDA approval requirements and the need for a medical countermeasure with established safety and efficacy for frontline nerve agent treatment as rationale for the sole source award. The contract would have a one-year base period and four one-year options, allowing flexible purchases over five years as requirements and product expiration dates change.
Notice text
This is a Justification and Approval (J&A) for brand name and is hereby posted as required by FAR 13.501(a)(iii). The J&A is attached to this notice.
Awarded contract 19AQMM23D0093 to unknown vendor for unknown amount on 2023-09-30.
Attachments
| File | Type | Posted |
|---|---|---|
| Mandrake 3.0 JOFOC FINAL - SAM.gov.pdf |
On GovTribe
Work this opportunity on GovTribe
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity